Dr. Connie Batlevi, MD, PhD, MS
Claim this profileMemorial Sloan Kettering Cancer Center
Area of expertise
Follicular Lymphoma
Connie Batlevi, MD, PhD, MS has run 3 trials for Follicular Lymphoma. Some of their research focus areas include:
Cancer
Connie Batlevi, MD, PhD, MS has run 1 trial for Cancer.
Affiliated Hospitals
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Bergen (All Protocol Activities)
Clinical Trials Connie Batlevi, MD, PhD, MS is currently running
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting
1 award
Phase 3
4 criteria
cfDNA Testing
for Follicular Lymphoma
The researchers are doing this study to measure and test cell-free DNA (cfDNA) in the blood before, during, and after first-line treatment for follicular lymphoma. They will look at whether cfDNA levels are related to a person's response to the usual first-line treatment for follicular lymphoma. Researchers also want to understand how different genetic changes in follicular lymphoma relate to a person's response to the usual first-line treatment.
Recruiting
1 award
Phase 1
5 criteria
More about Connie Batlevi, MD, PhD, MS
Clinical Trial Related
7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Connie Batlevi, MD, PhD, MS has experience with
- Abexinostat
- N-Acetylcysteine
- CfDNA
- Lenalidomide
- Rituximab
- Tazemetostat
Breakdown of trials Connie Batlevi, MD, PhD, MS has run
Follicular Lymphoma
Lymphoma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Connie Batlevi, MD, PhD, MS specialize in?
Connie Batlevi, MD, PhD, MS focuses on Follicular Lymphoma and Cancer. In particular, much of their work with Follicular Lymphoma has involved EZH2 positive patients, or patients who are CNG positive.
Is Connie Batlevi, MD, PhD, MS currently recruiting for clinical trials?
Yes, Connie Batlevi, MD, PhD, MS is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Connie Batlevi, MD, PhD, MS has studied deeply?
Yes, Connie Batlevi, MD, PhD, MS has studied treatments such as Abexinostat, N-Acetylcysteine, cfDNA.
What is the best way to schedule an appointment with Connie Batlevi, MD, PhD, MS?
Apply for one of the trials that Connie Batlevi, MD, PhD, MS is conducting.
What is the office address of Connie Batlevi, MD, PhD, MS?
The office of Connie Batlevi, MD, PhD, MS is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.